The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.
NEW YORK Interpublic Group’s Foote Cone & Belding is poised to assume direct-to-consumer advertising chores from pharmaceutical company Hoffman-La Roche for two drugs to treat hepatitis C, sources said. Annual media spending for upcoming campaigns could exceed $30 million, sources said.
FCB in New York competed in a review that included three other undisclosed agencies.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in